1he7: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="1he7" size="450" color="white" frame="true" align="right" spinBox="true" caption="1he7, resolution 2.0Å" /> '''HUMAN NERVE GROWTH F...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1he7.gif|left|200px]]<br />
[[Image:1he7.gif|left|200px]]<br /><applet load="1he7" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1he7" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1he7, resolution 2.0&Aring;" />
caption="1he7, resolution 2.0&Aring;" />
'''HUMAN NERVE GROWTH FACTOR RECEPTOR TRKA'''<br />
'''HUMAN NERVE GROWTH FACTOR RECEPTOR TRKA'''<br />


==Overview==
==Overview==
Nerve growth factor (NGF) is involved in the development and maintenance, of the nervous system and has been implicated as a possible therapeutic, target molecule in a number of neurodegenerative diseases, especially, Alzheimer's disease. NGF binds with high affinity to the extracellular, region of a tyrosine kinase receptor, TrkA, which comprises three, leucine-rich motifs (LRMs), flanked by two cysteine-rich clusters, followed by two immunoglobulin-like (Ig-like) domains. We have expressed, the second Ig-like domain as a recombinant protein in E. coli and, demonstrate that NGF binds to this domain with similar affinity to the, native receptor. This domain (TrkAIg(2)) has the ability to sequester NGF, in vitro, preventing NGF-induced neurite outgrowth, and in vivo, inhibiting NGF-induced plasma extravasation. We also present the, three-dimensional structure of the TrkAIg(2) domain in a new crystal form, refined to 2.0 A resolution.
Nerve growth factor (NGF) is involved in the development and maintenance of the nervous system and has been implicated as a possible therapeutic target molecule in a number of neurodegenerative diseases, especially Alzheimer's disease. NGF binds with high affinity to the extracellular region of a tyrosine kinase receptor, TrkA, which comprises three leucine-rich motifs (LRMs), flanked by two cysteine-rich clusters, followed by two immunoglobulin-like (Ig-like) domains. We have expressed the second Ig-like domain as a recombinant protein in E. coli and demonstrate that NGF binds to this domain with similar affinity to the native receptor. This domain (TrkAIg(2)) has the ability to sequester NGF in vitro, preventing NGF-induced neurite outgrowth, and in vivo, inhibiting NGF-induced plasma extravasation. We also present the three-dimensional structure of the TrkAIg(2) domain in a new crystal form, refined to 2.0 A resolution.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1HE7 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with GOL as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Transferase Transferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 and 2.7.10.2 2.7.10.1 and 2.7.10.2] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1HE7 OCA].  
1HE7 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=GOL:'>GOL</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Transferase Transferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 and 2.7.10.2 2.7.10.1 and 2.7.10.2] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HE7 OCA].  


==Reference==
==Reference==
Line 18: Line 17:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Transferase]]
[[Category: Transferase]]
[[Category: Allen, S.J.]]
[[Category: Allen, S J.]]
[[Category: Banfield, M.J.]]
[[Category: Banfield, M J.]]
[[Category: Bennett, G.S.]]
[[Category: Bennett, G S.]]
[[Category: Brady, R.L.]]
[[Category: Brady, R L.]]
[[Category: Brain, S.D.]]
[[Category: Brain, S D.]]
[[Category: Clarke, A.R.]]
[[Category: Clarke, A R.]]
[[Category: Dando, J.A.]]
[[Category: Dando, J A.]]
[[Category: Holden, P.H.]]
[[Category: Holden, P H.]]
[[Category: Mason, G.]]
[[Category: Mason, G.]]
[[Category: Naylor, R.L.]]
[[Category: Naylor, R L.]]
[[Category: Robertson, A.]]
[[Category: Robertson, A.]]
[[Category: Tyler, S.J.]]
[[Category: Tyler, S J.]]
[[Category: Wilcock, G.K.]]
[[Category: Wilcock, G K.]]
[[Category: GOL]]
[[Category: GOL]]
[[Category: nerve growth factor]]
[[Category: nerve growth factor]]
Line 37: Line 36:
[[Category: trk-receptor]]
[[Category: trk-receptor]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 17:16:55 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:00:20 2008''